Citation: Df. Moore et al., AN EMPIRICAL-MODEL FOR DETERMINING THE RADIAL FORCE-DEFLECTION CHARACTERISTICS OF OFF-ROAD BICYCLE TIRES, International journal of vehicle design, 17(4), 1996, pp. 471-482
Citation: Df. Moore et al., AMPLIFICATION OF RIBOSOMAL-RNA FOR ASSESSMENT OF TREATMENT RESPONSE OF PULMONARY TUBERCULOSIS PATIENTS DURING ANTIMICROBIAL THERAPY, Journal of clinical microbiology, 34(7), 1996, pp. 1745-1749
Citation: Aj. Pauza et al., ELECTRON-BEAM DAMAGE JOSEPHSON-JUNCTIONS - THE RELATION BETWEEN BEAM DAMAGE PROFILE AND ELECTRICAL-PROPERTIES, Czechoslovak journal of Physics, 46, 1996, pp. 1325-1326
Authors:
MOORE DF
SCHMIDT DR
MOORE DF
KOVACH KL
WEBER HP
Citation: Df. Moore et al., SEVERE METABOLIC-ACIDOSIS ASSOCIATED WITH THE THERAPEUTIC USE OF INTERLEUKIN-2 IN NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 3868-3868
Authors:
DEMEO LR
DRAPER DL
MCGREGOR JA
MOORE DF
PETER CR
KAPERNICK PS
MCCORMACK WM
Citation: Lr. Demeo et al., EVALUATION OF A DEOXYRIBONUCLEIC-ACID PROBE FOR THE DETECTION OF TRICHOMONAS-VAGINALIS IN VAGINAL SECRETIONS, American journal of obstetrics and gynecology, 174(4), 1996, pp. 1339-1342
Authors:
HARNISCH T
UHLMANN FH
TOPFER H
MOORE DF
PAUZA AJ
LAMACRAFT K
Citation: T. Harnisch et al., MODELING OF AN ADC BASED ON HIGH-T-C QOJS COMPARATORS, IEEE transactions on applied superconductivity, 5(2), 1995, pp. 2628-2631
Authors:
LINDSEY WH
HOARE JR
MOORE DF
GILES WG
GROSS CW
Citation: Wh. Lindsey et al., ENDOSCOPIC DIAGNOSIS AND TREATMENT OF NASOLACRIMAL DUCT CYSTS CAUSINGUPPER AIRWAY-OBSTRUCTION IN THE NEONATE, American journal of rhinology, 9(3), 1995, pp. 179-182
Citation: Df. Moore et al., WALDENSTROM MACROGLOBULINEMIA PRESENTING AS A RENAL OR PERIRENAL MASS- CLINICAL AND RADIOGRAPHIC FEATURES, Leukemia & lymphoma, 17(3-4), 1995, pp. 331-334
Authors:
STEVENS PE
MOORE DF
HOUSE IM
VOLANS GN
RAINFORD DJ
Citation: Pe. Stevens et al., SIGNIFICANT ELIMINATION OF BISMUTH BY HEMODIALYSIS WITH A NEW HEAVY-METAL CHELATING AGENT, Nephrology, dialysis, transplantation, 10(5), 1995, pp. 696-698
Authors:
MOORE DF
PAZDUR R
SUGARMAN S
JONES D
LIPPMAN SM
BREADY B
ABBRUZZESE JL
Citation: Df. Moore et al., PILOT PHASE-II TRIAL OF 13-CIS-RETINOIC ACID AND INTERFERON-ALPHA COMBINATION THERAPY FOR ADVANCED PANCREATIC ADENOCARCINOMA, American journal of clinical oncology, 18(6), 1995, pp. 525-527
Authors:
VISVESVARA GS
DASILVA AJ
CROPPO GP
PIENIAZEK NJ
LEITCH GJ
FERGUSON D
DEMOURA H
WALLACE S
SLEMENDA SB
TYRRELL I
MOORE DF
MEADOR J
Citation: Gs. Visvesvara et al., IN-VITRO CULTURE AND SEROLOGIC AND MOLECULAR-IDENTIFICATION OF SEPTATA-INTESTINALIS ISOLATED FROM URINE OF A PATIENT WITH AIDS, Journal of clinical microbiology, 33(4), 1995, pp. 930-936
Citation: Df. Moore et Ji. Curry, DETECTION AND IDENTIFICATION OF MYCOBACTERIUM-TUBERCULOSIS DIRECTLY FROM SPUTUM SEDIMENTS BY AMPLICOR PCR, Journal of clinical microbiology, 33(10), 1995, pp. 2686-2691
Authors:
SZARKA CE
PFEIFFER GR
HUM ST
EVERLEY LC
BALSHEM AM
MOORE DF
LITWIN S
GOOSENBERG EB
FRUCHT H
ENGSTROM PF
CLAPPER ML
Citation: Ce. Szarka et al., GLUTATHIONE-S-TRANSFERASE ACTIVITY AND GLUTATHIONE-S-TRANSFERASE MU-EXPRESSION IN SUBJECTS WITH RISK FOR COLORECTAL-CANCER, Cancer research, 55(13), 1995, pp. 2789-2793
Citation: Df. Moore et S. Vadhanraj, SUSTAINED RESPONSE IN FELTYS-SYNDROME TO PROLONGED ADMINISTRATION OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF), The American journal of medicine, 98(6), 1995, pp. 591-594
Authors:
PAZDUR R
MOORE DF
BREADY B
GIANNONE L
MALDONADO A
LIN YG
FUEGER RH
WINN RJ
LEVIN B
Citation: R. Pazdur et al., PHASE-II TRIAL OF EDATREXATE IN PATIENTS WITH ADVANCED HEPATOCELLULAR-CARCINOMA, Annals of oncology, 5(7), 1994, pp. 646-648
Authors:
MOORE DF
PAZDUR R
ABBRUZZESE JL
AJANI JA
DUBOVSKY DW
WADE JL
BELT RJ
MANGOLD C
BREADY B
WINN RJ
Citation: Df. Moore et al., PHASE-II TRIAL OF EDATREXATE IN PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA, Annals of oncology, 5(3), 1994, pp. 286-287
Authors:
MOORE DF
BENTLEY AM
DAWLING S
HOARE AM
HENRY JA
Citation: Df. Moore et al., FOLINIC ACID AND ENHANCED RENAL ELIMINATION IN FORMIC-ACID INTOXICATION, Journal of toxicology. Clinical toxicology, 32(2), 1994, pp. 199-204
Authors:
ROMAGUERA JE
RODRIGUEZ MA
HAGEMEISTER FB
MCLAUGHLIN P
SWAN F
MOORE DF
SARRIS AH
YOUNES A
HILL D
CABANILLAS F
Citation: Je. Romaguera et al., A PHASE-II TRIAL OF ORAL ETOPOSIDE WITH MITOXANTRONE AND IFOSFAMIDE MESNA CONSOLIDATED WITH INTRAVENOUS ETOPOSIDE, METHYLPREDNISOLONE, HIGH-DOSE ARABINOSIDE, AND CISPLATIN AS SALVAGE THERAPY FOR RELAPSING AND OR REFRACTORY LYMPHOMAS/, Investigational new drugs, 12(3), 1994, pp. 217-222
Citation: Df. Moore et al., PHASE-II TRIAL OF INTRAVENOUS MELPHALAN IN ADVANCED COLORECTAL-CARCINOMA, Investigational new drugs, 12(2), 1994, pp. 133-136